Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Trellus Health PLC ( (GB:TRLS) ) is now available.
Trellus Health plc has issued 16,438,845 new ordinary shares following the conversion of £50,000 of principal from the second tranche of its secured convertible loan notes, with the issuance slightly reduced to offset an earlier over-allotment to Alumni Capital LLC. The new shares, which represent around 0.2% of the company’s issued share capital, are not considered material, but will lift total voting rights to 241,612,340 once admission to trading on AIM is expected to become effective around 13 March 2026, providing an updated reference point for shareholder disclosure thresholds under FCA rules.
The most recent analyst rating on (GB:TRLS) stock is a Hold with a £0.74 price target. To see the full list of analyst forecasts on Trellus Health PLC stock, see the GB:TRLS Stock Forecast page.
Spark’s Take on GB:TRLS Stock
According to Spark, TipRanks’ AI Analyst, GB:TRLS is a Neutral.
The score is held down primarily by weak financial performance—large ongoing losses, negative free cash flow, and declining equity—despite the benefit of having no debt. Technicals are the main positive, with strong momentum above major moving averages, but valuation remains constrained by loss-making results and no indicated dividend yield.
To see Spark’s full report on GB:TRLS stock, click here.
More about Trellus Health PLC
Trellus Health plc is a healthcare company that delivers Trellus Elevate, a digital, resilience-based platform that integrates data analytics, personalised self-management programmes and expert coaching to support people with complex chronic conditions. The company initially targets high-cost gastrointestinal diseases such as inflammatory bowel disease and also partners with pharmaceutical firms to support clinical trials and commercial patient programmes.
Average Trading Volume: 6,749,239
Technical Sentiment Signal: Sell
Current Market Cap: £1.18M
For detailed information about TRLS stock, go to TipRanks’ Stock Analysis page.